Connected Care: Special Announcement
Teva’s new clinician site says most schizophrenia patients stop taking daily pills — and most relapse anyway. Here’s why long-acting injectables deserve an earlier conversation.
Tag: LAI
Teva’s new clinician site says most schizophrenia patients stop taking daily pills — and most relapse anyway. Here’s why long-acting injectables deserve an earlier conversation.